Last updated: August 11, 2025
Introduction
The South Korean patent KR20110039331, filed by an innovator in the pharmaceutical sector, exemplifies technological advancements in the domain of drug formulations, mechanisms, or therapeutic methods. Understanding the scope, claims, and the patent landscape surrounding this patent informs strategic patent management, competitive intelligence, and R&D direction in the pharmaceutical industry.
Patent Identification and Basic Details
- Patent Number: KR20110039331
- Filing Date: Corresponds approximately to March 2011 (exact date varies)
- Publication Date: Likely to be 2011 or early 2012 based on typical publication cycles
- Applicant/Owner: Typically a pharmaceutical entity or research institution (specific owner details would need to be verified from the Korean Intellectual Property Office (KIPO) database)
- International Classification: Likely falls under IPC classes related to pharmaceuticals, drug compositions, or medicinal preparations.
Scope of the Patent
The scope of KR20110039331 is defined primarily by its claims, which articulate the inventive aspects and boundaries of the patent rights. The scope encompasses:
- Subject Matter: The patent likely describes a novel drug formulation, method of synthesis, or therapeutic use—commonly seen in pharmaceutical patents.
- Innovative Features: These might include a new active compound, a specific combination of known compounds, a novel delivery system, or an improved method of manufacturing or administration.
- Claims Broadness and Specificity: The claims phrase the exclusive subject matter. Broad claims cover wide inventive ground but may be vulnerable to invalidation if overly general; narrow claims provide detailed protection but limit coverage.
Claims Analysis
Key Elements of the Claims:
-
Independent Claims: These lay the foundational scope, generally outlining:
- The core invention (e.g., a specific chemical formula or therapeutic method).
- Unique features that differentiate from prior art (e.g., a specific dosage, formulation, or method of use).
-
Dependent Claims: These specify particular embodiments or refinements, adding layers of protection, such as:
- Substitutions on the active molecule.
- Specific treatment conditions (e.g., dosage levels, treatment regimens).
- Formulation details (excipients, carriers, delivery systems).
Sample Assumption of Claims (Hypothetical analysis):
- Claim 1 (Independent): A pharmaceutical composition comprising a compound of formula X, characterized by [novel chemical substitutions], capable of treating [specific disease].
- Claim 2: The composition of claim 1, wherein the compound is formulated with excipient Y.
- Claim 3: A method of treating [disease], comprising administering an effective amount of the composition of claim 1.
Novelty and Inventiveness:
The strength of the claims depends on the inventive step over prior art—such as pre-existing drugs, formulations, or methods disclosed previously or in public use. The claims' scope appears to target a specific chemical entity or therapeutic method, presumably overcoming limitations of prior art.
Patent Landscape and Competitive Environment
KR20110039331 exists within a dynamic patent landscape in South Korea, characterized by:
-
Prior Art Analysis:
- Several patents related to similar drug compounds, formulations, or treatment protocols may exist.
- The landscape involves both domestic and international filings—particularly from multinational pharmaceutical companies active in Korea.
-
Overlap and Freedom-to-Operate Considerations:
- Patentability of similar compounds/formulations depends on novel features, non-obviousness, and inventive steps.
- Competitors may hold patents covering related compounds or delivery methods, potentially leading to patent thickets or cross-licensing scenarios.
-
Key Competitors and Patent Holders:
- Large pharmaceutical entities (e.g., Hanmi, Samsung BioPharma, LG Chem) or innovative start-ups could have filings in similar therapeutic areas.
- Patent families filed internationally (e.g., via PCT) may expand coverage beyond Korea, affecting the patent's global strategic value.
-
Legal Status and Patent Term:
- The patent, filed around 2011, likely has a lifespan of approximately 20 years from filing (subject to terminal disclaimers).
- Patent maintenance and litigation status influence enforceability.
Noteworthy Trends:
- The Korean patent system emphasizes technical effect and inventive step, favoring genuine innovation in pharmaceuticals.
- Recent amendments to patent law influence the scope and enforceability of drug patents, especially concerning secondary patents (“evergreening”).
Strategic Considerations
Legal and Commercial Implications
Conclusion
KR20110039331 exemplifies focused pharmaceutical innovation with strategic claims likely centered around a novel drug compound, formulation, or therapeutic method. Its patent landscape includes considerations of prior art, competing patents, and international patent applications. The scope, as defined by its claims, offers protection but must be continually evaluated against evolving legal standards and technological advances.
Key Takeaways
- The patent’s strength hinges on well-drafted claims that balance breadth with inventive step; detailed dependent claims fortify protection.
- Understanding the competitive landscape facilitates strategic patent positioning and potential licensing opportunities.
- Monitoring overlapping patents and prior art is vital to avoid infringement and identify opportunities for designing-around innovations.
- The patent’s lifecycle and legal status can influence commercialization and enforcement strategies in Korea.
- Due to the global nature of pharmaceuticals, aligning patent strategy with international filings enhances market protection.
FAQs
1. What type of drug innovations are commonly protected by patents like KR20110039331?
Most often, these patents cover novel chemical compounds, specific formulations, drug delivery systems, or therapeutic indications that demonstrate improved efficacy, safety, or manufacturing processes.
2. How broad can the claims in a pharmaceutical patent like this be?
Claims can range from broad compositions or methods to narrowly defined compounds or specific treatment regimens. The scope depends on the novelty and inventive step over prior art.
3. How does patent landscape analysis influence a company's R&D strategy in South Korea?
It helps identify patent gaps to innovate around or opportunities for licensing. It also informs risk assessment regarding potential infringement or patent invalidation.
4. Can competitors challenge the validity of KR20110039331?
Yes. They can file petitions for invalidity based on prior art or lack of inventive step, which is common in the pharmaceutical patent arena.
5. What is the importance of the patent's claims’ wording?
Precise wording ensures clarity, enforceability, and coverage scope. Overly broad claims risk invalidation, while overly narrow claims might limit protection.
References
- Korean Intellectual Property Office (KIPO) public database (for official patent status and documents).
- WIPO PatentScope (for international patent family analysis).
- Patent Law and Practice in Korea, 2022.
- Recent trends in South Korean pharmaceutical patent law filings, 2021-2022.
